IL-10: a novel cytotoxic T cell differentiation factor
- PMID: 1906502
IL-10: a novel cytotoxic T cell differentiation factor
Abstract
A previous report concluded that a new cytokine, designated IL-10, is a growth cofactor for thymocytes, spleen, and lymph node cells. In this report, we have focused on the effects of IL-10 on CD8+ spleen T cells. We first observed that IL-10 enhances the growth of CD8+ T cells to IL-2. We then investigated the effect of murine rIL-10 on the induction of murine effector CTL from CTL precursors (CTL-p) using both bulk and filler cell-free limiting-dilution cultures. IL-10 alone could not induce Con A-activated FACS-sorted CD8+ T cells either to proliferate or to generate effector CTL. In combination with IL-2, however, IL-10 augmented the cytolytic activity of effector CTL generated from Con A-activated spleen CD8+ T cells in bulk cultures incubated for 5 days. In limiting-dilution cultures (using solid-phase anti-CD3 mAb as stimulus), IL-10, in combination with IL-2, substantially increased the CTL-p frequency and augmented the cytolytic activity per clone expanded from one CD8+ T cell when compared with cells cultured in IL-2 alone. Kinetic studies showed that IL-10 is required at both early and late culture stages for optimal generation of effector CTL. The potentiating effects of IL-10 on CTL function were neutralized by an anti-IL-10 mAb. These results indicate that IL-10 has direct effects on mature T cells, and suggest that IL-10 also functions as a cytotoxic T cell differentiation factor, which promotes a higher number of IL-2-activated CTL-p to proliferate and differentiate into effector CTL. In contrast, IL-10 did not enhance significantly the lymphokine-activated killer cell activity of IL-2-grown CD8+ cytotoxic T cells.
Similar articles
-
Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells.Eur J Immunol. 1985 May;15(5):472-8. doi: 10.1002/eji.1830150511. Eur J Immunol. 1985. PMID: 3158532
-
IL-2 and IFN-gamma are two necessary lymphokines in the development of cytolytic T cells.J Immunol. 1989 Aug 15;143(4):1210-4. J Immunol. 1989. PMID: 2501391
-
IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.J Immunol. 1988 Sep 1;141(5):1543-9. J Immunol. 1988. PMID: 3261754
-
Differentiation and functions of T cell subsets.Ciba Found Symp. 1997;204:148-54; discussion 154-8. doi: 10.1002/9780470515280.ch10. Ciba Found Symp. 1997. PMID: 9107418 Review.
-
Interleukin-12.J Leukoc Biol. 1994 Feb;55(2):280-8. doi: 10.1002/jlb.55.2.280. J Leukoc Biol. 1994. PMID: 7905508 Review.
Cited by
-
IL-10 implications in psoriasis.Int J Health Sci (Qassim). 2008 Jan;2(1):53-8. Int J Health Sci (Qassim). 2008. PMID: 21475472 Free PMC article.
-
Dual biological effects of the cytokines interleukin-10 and interferon-γ.Cancer Immunol Immunother. 2011 Nov;60(11):1529-41. doi: 10.1007/s00262-011-1104-5. Epub 2011 Sep 15. Cancer Immunol Immunother. 2011. PMID: 21918895 Free PMC article.
-
The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions.Front Immunol. 2023 Jun 8;14:1161067. doi: 10.3389/fimmu.2023.1161067. eCollection 2023. Front Immunol. 2023. PMID: 37359549 Free PMC article. Review.
-
Nonclassical roles for IFN-γ and IL-10 in a murine model of immunoedition.Future Sci OA. 2020 Oct 27;6(10):FSO589. doi: 10.2144/fsoa-2019-0108. Future Sci OA. 2020. PMID: 33312693 Free PMC article.
-
IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes.Clin Exp Immunol. 2000 Mar;119(3):426-32. doi: 10.1046/j.1365-2249.2000.01147.x. Clin Exp Immunol. 2000. PMID: 10691913 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials